Chescapmanager LLC Pardes Biosciences, Inc. Transaction History

Chescapmanager LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.4 - $1.95 $700 - $975	500 Added 0.03%	1,672,379 $3.03 Million
Q1 2023 May 15, 2023	BUY	$1.21 - $2.22 $1.41 Million - $2.58 Million	1,162,492 Added 228.21%	1,671,879 $2.21 Million
Q4 2022 Feb 14, 2023	BUY	$0.85 - $1.69 $125,520 - $249,563	147,671 Added 40.83%	509,387 $861,000
Q2 2022 Aug 12, 2022	SELL	$2.84 - $8.57 $637,040 - $1.92 Million	-224,310 Reduced 38.28%	361,716 $1.11 Million
Q1 2022 May 13, 2022	SELL	$5.64 - $15.64 $2.17 Million - $6.02 Million	-385,088 Reduced 39.65%	586,026 $4.23 Million
Q4 2021 Feb 11, 2022	BUY	$9.8 - $17.02 $9.52 Million - $16.5 Million	971,114 New	971,114 $15.9 Million

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Chescapmanager LLC, based on Form 13F filings with the SEC.

Stay updated on Chescapmanager LLC with notifications on news.